node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
CNR1 | CNR2 | ENSMLUP00000013631 | ENSMLUP00000017112 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | 0.912 |
CNR1 | DRD2 | ENSMLUP00000013631 | ENSMLUP00000010834 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Dopamine receptor D2; Belongs to the G-protein coupled receptor 1 family. | 0.927 |
CNR1 | G1PJN7_MYOLU | ENSMLUP00000013631 | ENSMLUP00000010974 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Uncharacterized protein. | 0.929 |
CNR1 | GNAI1 | ENSMLUP00000013631 | ENSMLUP00000004841 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | G protein subunit alpha i1. | 0.930 |
CNR1 | GNAI2 | ENSMLUP00000013631 | ENSMLUP00000002148 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | G protein subunit alpha i2. | 0.930 |
CNR1 | GNAI3 | ENSMLUP00000013631 | ENSMLUP00000003976 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | G protein subunit alpha i3. | 0.931 |
CNR1 | GNB3 | ENSMLUP00000013631 | ENSMLUP00000006150 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | G protein subunit beta 3. | 0.929 |
CNR1 | GNB5 | ENSMLUP00000013631 | ENSMLUP00000006291 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | G protein subunit beta 5. | 0.930 |
CNR1 | GPR18 | ENSMLUP00000013631 | ENSMLUP00000015510 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | G protein-coupled receptor 18; Belongs to the G-protein coupled receptor 1 family. | 0.787 |
CNR1 | GPR55 | ENSMLUP00000013631 | ENSMLUP00000003033 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | G protein-coupled receptor 55; Belongs to the G-protein coupled receptor 1 family. | 0.851 |
CNR2 | CNR1 | ENSMLUP00000017112 | ENSMLUP00000013631 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | 0.912 |
CNR2 | DRD2 | ENSMLUP00000017112 | ENSMLUP00000010834 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | Dopamine receptor D2; Belongs to the G-protein coupled receptor 1 family. | 0.816 |
CNR2 | G1PJN7_MYOLU | ENSMLUP00000017112 | ENSMLUP00000010974 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | Uncharacterized protein. | 0.794 |
CNR2 | GNAI1 | ENSMLUP00000017112 | ENSMLUP00000004841 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | G protein subunit alpha i1. | 0.809 |
CNR2 | GNAI2 | ENSMLUP00000017112 | ENSMLUP00000002148 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | G protein subunit alpha i2. | 0.809 |
CNR2 | GNAI3 | ENSMLUP00000017112 | ENSMLUP00000003976 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | G protein subunit alpha i3. | 0.809 |
CNR2 | GNB3 | ENSMLUP00000017112 | ENSMLUP00000006150 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | G protein subunit beta 3. | 0.820 |
CNR2 | GNB5 | ENSMLUP00000017112 | ENSMLUP00000006291 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | G protein subunit beta 5. | 0.822 |
CNR2 | GPR18 | ENSMLUP00000017112 | ENSMLUP00000015510 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | G protein-coupled receptor 18; Belongs to the G-protein coupled receptor 1 family. | 0.794 |
CNR2 | GPR55 | ENSMLUP00000017112 | ENSMLUP00000003033 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | G protein-coupled receptor 55; Belongs to the G-protein coupled receptor 1 family. | 0.822 |